Precigen, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing gene and cell therapies to address significant unmet medical needs. Founded in 2013, Precigen has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and genetic medicine. The company is renowned for its innovative platforms, including UltraCAR-T™ and AdenoVerse™, which enable the development of unique therapies designed to enhance patient outcomes. With a commitment to transforming healthcare, Precigen has achieved notable milestones, including strategic partnerships and advancements in clinical trials. Positioned as a leader in the biotechnology sector, Precigen continues to push the boundaries of science, striving to deliver cutting-edge solutions that redefine treatment paradigms and improve the lives of patients worldwide.
How does Precigen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Precigen, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Precigen, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Precigen may not have established formal commitments to reduce its carbon footprint or may not be publicly disclosing such information at this time. As a result, the company's climate strategy and initiatives remain unclear within the context of industry standards for emissions reporting and reduction.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Precigen, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
